De Meester I - Search Results

1

CD26/DPP4 - a potential biomarker and target for cancer therapy.

Enz N, Vliegen G, De Meester I, Jungraithmayr W. Enz N, et al. Among authors: de meester i. Pharmacol Ther. 2019 Jun;198:135-159. doi: 10.1016/j.pharmthera.2019.02.015. Epub 2019 Feb 26. Pharmacol Ther. 2019. PMID: 30822465 Review.

2

Binding of adenosine deaminase to the lymphocyte surface via CD26.

De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P, Scharpé S. De Meester I, et al. Eur J Immunol. 1994 Mar;24(3):566-70. doi: 10.1002/eji.1830240311. Eur J Immunol. 1994. PMID: 7907293

3

CD26, let it cut or cut it down.

De Meester I, Korom S, Van Damme J, Scharpé S. De Meester I, et al. Immunol Today. 1999 Aug;20(8):367-75. doi: 10.1016/s0167-5699(99)01486-3. Immunol Today. 1999. PMID: 10431157 Review.

4

A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro.

Lambeir AM, Proost P, Scharpé S, De Meester I. Lambeir AM, et al. Among authors: de meester i. Biochem Pharmacol. 2002 Dec 15;64(12):1753-6. doi: 10.1016/s0006-2952(02)01415-6. Biochem Pharmacol. 2002. PMID: 12445864

5

Dipeptidyl peptidase II and leukocyte cell death.

Maes MB, Martinet W, Schrijvers DM, Van der Veken P, De Meyer GR, Augustyns K, Lambeir AM, Scharpé S, De Meester I. Maes MB, et al. Among authors: de meester i, de meyer gr. Biochem Pharmacol. 2006 Jun 28;72(1):70-9. doi: 10.1016/j.bcp.2006.04.009. Epub 2006 Apr 25. Biochem Pharmacol. 2006. PMID: 16725115

6

Ischemia/reperfusion injury: The role of CD26/dipeptidyl-peptidase-IV-inhibition in lung transplantation.

Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I, Arni S, Jungraithmayr W, Scharpé S, Weder W, Korom S. Zhai W, et al. Among authors: de meester i. Transplant Proc. 2006 Dec;38(10):3369-71. doi: 10.1016/j.transproceed.2006.10.048. Transplant Proc. 2006. PMID: 17175274

7

Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia.

Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I, Arni S, Jungraithmayr W, Scharpé S, Weder W, Korom S. Zhai W, et al. Among authors: de meester i. J Heart Lung Transplant. 2007 Feb;26(2):174-80. doi: 10.1016/j.healun.2006.11.601. J Heart Lung Transplant. 2007. PMID: 17258152

8

DPP4 inhibitors for diabetes--what next?

Lambeir AM, Scharpé S, De Meester I. Lambeir AM, et al. Among authors: de meester i. Biochem Pharmacol. 2008 Dec 15;76(12):1637-43. doi: 10.1016/j.bcp.2008.07.029. Epub 2008 Jul 31. Biochem Pharmacol. 2008. PMID: 18755155 Review.

9

Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide.

Zhai W, Jungraithmayr W, De Meester I, Inci I, Augustyns K, Arni S, Hillinger S, Scharpé S, Weder W, Korom S. Zhai W, et al. Among authors: de meester i. Transplantation. 2009 Apr 27;87(8):1140-6. doi: 10.1097/TP.0b013e31819e04c3. Transplantation. 2009. PMID: 19384159

10

The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection.

Jungraithmayr W, Oberreiter B, De Meester I, Wiedl T, Inci I, Bain M, Augustyns K, Hillinger S, Scharpé S, Weder W, Korom S. Jungraithmayr W, et al. Among authors: de meester i. Transplantation. 2009 Aug 27;88(4):478-85. doi: 10.1097/TP.0b013e3181b08e77. Transplantation. 2009. PMID: 19696630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters